Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2094254 Target Snapshot

Cysteinyl leukotriene receptor · PROTEIN FAMILY · Homo sapiens

826Compounds
53Assays
6Approved Drugs
497.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q9Y271. Use UniProt Q9Y271 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Y271 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cysteinyl leukotriene receptor as ChEMBL target CHEMBL2094254, mapped to UniProt Q9Y271. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cysteinyl leukotriene receptor
PROTEIN FAMILY · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL2094254
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q9Y271
Cysteinyl leukotriene receptor 1
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cysteinyl leukotriene receptor is the right protein anchor across sources, using UniProt Q9Y271 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCysteinyl leukotriene receptor 1
UniProt AccessionQ9Y271
Component TypeProtein
Sequence Length337 aa

Cysteinyl leukotriene receptor 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cysteinyl leukotriene receptor, mapped to UniProt Q9Y271. ChEMBL maps the protein component as Cysteinyl leukotriene receptor 1. Sequence length is 337 aa.

Mapped IDQ9Y271
Review nameCysteinyl leukotriene receptor
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

6
Approved
4
Phase II
Assay Mix

Activity Type Distribution

IC50322.0
KI127.0
KD48.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL354129 10.51 IC50 0.031 Preclinical
CHEMBL21333 10.36 IC50 0.044 Approved
CHEMBL171021 10.22 IC50 0.06 Preclinical
CHEMBL299837 10.0 Ki 0.1 Preclinical
CHEMBL169790 9.96 IC50 0.11 Preclinical
CHEMBL354530 9.85 IC50 0.14 Preclinical
CHEMBL170191 9.8 IC50 0.16 Preclinical
CHEMBL343934 9.77 IC50 0.17 Preclinical
CHEMBL344180 9.72 IC50 0.19 Preclinical
CHEMBL313187 9.7 IC50 0.2 Preclinical
Distribution

pChEMBL Value Distribution

22
5.0
33
5.5
66
6.0
66
6.5
59
7.0
59
7.5
43
8.0
38
8.5
59
9.0
25
9.5
pChEMBL
Approved Drugs

Approved Drugs

MONTELUKAST
CHEMBL787
Approved 1998
ZAFIRLUKAST
CHEMBL603
Approved 1996
PRANLUKAST
CHEMBL21333
Approved 1995
Assay Landscape

Assay Landscape

53
Total Assays
232
Tested Compounds
2
Assay Types
Functional — 36 assays, 191 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 16 171 7.3
organism-based format 15 0
assay format 5 20 6.6
Binding — 17 assays, 232 compounds
BAO Format Assays Compounds Avg pChEMBL
tissue-based format 8 122 8.4
assay format 4 11 5.8
cell membrane format 3 88 6.2
protein format 2 11 7.5

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine